Evidence map›Paper›PMID 33616085›Full record

ArticleJCI insight2021

B cells modulate mouse allergen-specific T cells in nonallergic laboratory animal-care workers.

Esther Dawen Yu, Luise Westernberg, Alba Grifoni, April Frazier, Aaron Sutherland, Eric Wang, Bjoern Peters, Ricardo da Silva Antunes, Alessandro Sette

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Cell reports methods · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Esther Dawen YuLa Jolla Institute for Immunology, La Jolla, California, USA.
Luise WesternbergLa Jolla Institute for Immunology, La Jolla, California, USA.
Alba GrifoniLa Jolla Institute for Immunology, La Jolla, California, USA.
April FrazierLa Jolla Institute for Immunology, La Jolla, California, USA.
Aaron SutherlandLa Jolla Institute for Immunology, La Jolla, California, USA.
Eric WangLa Jolla Institute for Immunology, La Jolla, California, USA.
Bjoern PetersLa Jolla Institute for Immunology, La Jolla, California, USA.
Ricardo da Silva AntunesLa Jolla Institute for Immunology, La Jolla, California, USA.
Alessandro SetteLa Jolla Institute for Immunology, La Jolla, California, USA.
La Jolla Institute for Immunology · US

Funding

Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
Towards the identification of biomarkers for pediatric milk allergyU19AI135731 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2018 to 2022
$5.6M
NIAID NIH HHS U19 AI100275NIAID NIH HHS U19 AI135731
6 · The paper itself

Abstract

Understanding the mechanisms of allergen-specific immune modulation in nonallergic individuals is key to recapitulate immune tolerance and to develop novel allergy treatments. Herein, we characterized mouse-specific T cell responses in nonallergic laboratory animal-care workers before and after reexposure to mice. PBMCs were collected and stimulated with developed peptide pools identified from high-molecular-weight fractions of mouse allergen extracts. Sizable CD4 T cell responses were noted and were temporarily decreased in most subjects upon reexposure, with the magnitude of decrease positively correlated with time of reexposure but not the duration of the break. Interestingly, the suppression was specific to mouse allergens without affecting responses of bystander antigens. Further, PBMC fractioning studies illustrated that the modulation is unlikely from T cells, while B cell depletion and exchange reversed the suppression of responses, suggesting that B cells may be the key modulators. Increased levels of regulatory cytokines (IL-10 and TGF-β1) in the cell culture supernatant and plasma mouse-specific IgG4 were also observed after reexposure, consistent with B cell-mediated modulation mechanisms. Overall, these results suggest that nonallergic status is achieved by an active, time-related, allergen-specific, B cell-dependent regulatory process upon reexposure, the mechanisms of which should be detailed by further molecular studies.

Indexed as

Animals, LaboratoryAdultAllergensAnimalsB-LymphocytesCytokinesDown-RegulationFemaleHumansHypersensitivityImmune ToleranceInterleukin-10MaleMiceT-LymphocytesAllergensCytokinesIL10 protein, humanInterleukin-10AllergyAntigenImmunologyT cells

Identifiers

PMID33616085
PMCPMC7934936
OpenAlexW3131277680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.